Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126478531 | 12647853 | 1 | I | 20160804 | 20160812 | 20160812 | EXP | BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-064504 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160812 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126478531 | 12647853 | 1 | PS | ABATACEPT | ABATACEPT | 1 | Subcutaneous | 125 MG, QWK | Y | 125118 | 125 | MG | SOLUTION FOR INJECTION | /wk | |||||
| 126478531 | 12647853 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126478531 | 12647853 | 1 | Rheumatoid arthritis |
| 126478531 | 12647853 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126478531 | 12647853 | OT |
| 126478531 | 12647853 | LT |
| 126478531 | 12647853 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126478531 | 12647853 | Immunodeficiency | |
| 126478531 | 12647853 | Meningitis | |
| 126478531 | 12647853 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |